Feb 29 (Reuters) - Elixinol Wellness Ltd (EXL) :
- RECONFIRMS FY24 REVENUE GUIDANCE OF A$16M - A$20M AND EBITDA BREAKEVEN BY MID-FY24
- FY23 REVENUE OF A$8.3M, UP 17%
- FY ADJUSTED EBITDA LOSS OF A$4.6M VERSUS LOSS OF A$8.5M
Feb 29 (Reuters) - Elixinol Wellness Ltd (EXL) : RECONFIRMS...
Add to My Watchlist
What is My Watchlist?